144 related articles for article (PubMed ID: 9516845)
1. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.
Anderson CP; Tsai J; Chan W; Park CK; Tian L; Lui RM; Forman HJ; Reynolds CP
Eur J Cancer; 1997 Oct; 33(12):2016-9. PubMed ID: 9516845
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
3. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.
Anderson CP; Seeger RC; Satake N; Monforte-Munoz HL; Keshelava N; Bailey HH; Reynolds CP
J Pediatr Hematol Oncol; 2001 Nov; 23(8):500-5. PubMed ID: 11878777
[TBL] [Abstract][Full Text] [Related]
4. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.
Anderson CP; Tsai JM; Meek WE; Liu RM; Tang Y; Forman HJ; Reynolds CP
Exp Cell Res; 1999 Jan; 246(1):183-92. PubMed ID: 9882527
[TBL] [Abstract][Full Text] [Related]
5. The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.
Tagde A; Singh H; Kang MH; Reynolds CP
Blood Cancer J; 2014 Jul; 4(7):e229. PubMed ID: 25036800
[TBL] [Abstract][Full Text] [Related]
6. Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression.
Anderson CP; Keshelava N; Satake N; Meek WH; Reynolds CP
Med Pediatr Oncol; 2000 Dec; 35(6):659-62. PubMed ID: 11107141
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells.
Vahrmeijer AL; van Dierendonck JH; Schutrups J; van de Velde CJ; Mulder GJ
Biochem Pharmacol; 1999 Aug; 58(4):655-64. PubMed ID: 10413303
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
10. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
Cuperus R; van Kuilenburg AB; Leen R; Bras J; Caron HN; Tytgat GA
Free Radic Biol Med; 2011 Sep; 51(6):1213-20. PubMed ID: 21741474
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
Bailey HH; Mulcahy RT; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Wilding G; Pomplun M; Spriggs DR
J Clin Oncol; 1994 Jan; 12(1):194-205. PubMed ID: 8270977
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Anderson CP; Matthay KK; Perentesis JP; Neglia JP; Bailey HH; Villablanca JG; Groshen S; Hasenauer B; Maris JM; Seeger RC; Reynolds CP
Pediatr Blood Cancer; 2015 Oct; 62(10):1739-46. PubMed ID: 26153194
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
Dorr RT; Liddil JD; Soble MJ
Invest New Drugs; 1986; 4(4):305-13. PubMed ID: 3583642
[TBL] [Abstract][Full Text] [Related]
14. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
15. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
Pigment Cell Res; 1997 Aug; 10(4):236-49. PubMed ID: 9263331
[TBL] [Abstract][Full Text] [Related]
16. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
Chem Biol Interact; 1998 Apr; 111-112():277-305. PubMed ID: 9679561
[TBL] [Abstract][Full Text] [Related]
17. A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Villablanca JG; Volchenboum SL; Cho H; Kang MH; Cohn SL; Anderson CP; Marachelian A; Groshen S; Tsao-Wei D; Matthay KK; Maris JM; Hasenauer CE; Czarnecki S; Lai H; Goodarzian F; Shimada H; Reynolds CP
Pediatr Blood Cancer; 2016 Aug; 63(8):1349-56. PubMed ID: 27092812
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat: enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery.
Vahrmeijer AL; van Dierendonck JH; Schutrups J; van de Velde CJ; Mulder GJ
Cancer Chemother Pharmacol; 1999; 44(2):111-6. PubMed ID: 10412944
[TBL] [Abstract][Full Text] [Related]
19. Reduced thiol content in L1210 cells treated with BSO increases DNA crosslinking by melphalan.
Dorr RT
Biochem Biophys Res Commun; 1987 Apr; 144(1):47-52. PubMed ID: 3579919
[TBL] [Abstract][Full Text] [Related]
20. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis.
Stokes AH; Lewis DY; Lash LH; Jerome WG; Grant KW; Aschner M; Vrana KE
Brain Res; 2000 Mar; 858(1):1-8. PubMed ID: 10700589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]